Journal Mobile Options
Table of Contents
Vol. 12, No. 1, 1974
Issue release date: 1974
Add to my selection Citation Download
Nephron 1974;12:1–9
(DOI:10.1159/000180250)
Paper

Dialysis Bone Disease

A Quantitative Histologic Study

Binswanger U. · Sherrard D. · Rich C. · Curtis F.K.
Veterans Administrations Hospital and University of Washington School of Medicine, Seattle, Wash. Nephron 1974;12:1–9 (DOI:10.1159/000180250)

Abstract

15 patients on chronic hemodialysis were investigated by means of quantitative bone histology. Bone changes were found regularly in the absence of clinical signs. They were not qualitatively different from those seen in nondialyzed uremic.

 goto top of outline Author Contacts

Request reprints from: Ulrich Binswanger, MD, Klinischer Oberarzt, Medizinische Universitätsklinik, CH-8006 Zürich (Switzerland)


 goto top of outline Article Information

Number of Print Pages : 9


 goto top of outline Publication Details

Nephron

Vol. 12, No. 1, Year 1974 (Cover Date: 1974)

Journal Editor: Fine L.G. (Los Angeles, Calif.)
ISSN: 0028–2766 (Print), eISSN: 1423–0186 (Online)

For additional information: http://www.karger.com/NEF


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.